Abstract
Multiple sclerosis (MS) is one of the most common chronic neurological diseases affecting the central nervous system in young adults. To investigate demographic and clinical factors that are effective in the development of irreversible disability from the onset of MS, and to identify factors that affect the transformation from the relapse-remitting MS (RRMS) phase to the progressive MS (PMS) phase. Retrospective study on 741 patients who were diagnosed with RRMS and PMS according to the McDonald criteria, and were enrolled into the Turkish MS database of the Department of Neurology MS Polyclinic, at the Faculty of Medicine, Karadeniz Technical University, in Trabzon, Turkey. Kaplan-Meier analysis was used to evaluate the time taken to reach EDSS 4 and EDSS 6 from the onset of disease, and the time taken between EDSS 4 and EDSS 6. Age of onset >40 years; having polysymptomatic-type onset, pyramidal or bladder-intestinal system-related first episode; ≥7 episodes in the first 5 years; and <2 years between the first two episodes were found to be effective for MS patients to reach EDSS 4 and EDSS 6. The demographic and clinical parameters that were effective for progression from EDSS 4 to EDSS 6 were: pyramidal or bladder-intestinal system-related first episode; 4‒6 episodes in the first 5 years; >2 years until start of first treatment; and smoking. Our findings reveal important characteristics of MS patients in our region. However, the associations between these parameters and MS pathophysiology remain to be elucidated.
Highlights
Multiple sclerosis (MS) is one of the most common chronic neurological diseases affecting the central nervous system (CNS) in young adults
The first and the most common type is relapsing-remitting multiple sclerosis (RRMS), which is characterised by relapses of new or increasing neurological symptoms that are followed by periods of partial
We aimed to determine the demographic and clinical factors that are effective for development of irreversible disability from the onset of disease, and to identify factors that affect the transformation from the relapse-remitting MS (RRMS) phase to the secondary progressive MS (SPMS) phase
Summary
Multiple sclerosis (MS) is one of the most common chronic neurological diseases affecting the central nervous system (CNS) in young adults. MS progresses with inflammatory demyelination and subsequent axonal loss, which causes a wide range of unpredictable functional disabilities that are associated with the CNS region(s) affected[2,3]. It was reported in 2013 that around 2.3 million people suffer from MS on a global scale[4]. Multiple sclerosis (MS) is one of the most common chronic neurological diseases affecting the central nervous system in young adults. The associations between these parameters and MS pathophysiology remain to be elucidated
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.